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82 The Journal of Thoracic and Cardiobjective: A gamma probe can identify sentinel nodes before nodal dissection in the
ediastinum but not in the hilum, owing to high radioactivity from primary tumors.
e evaluated the utility of fused single photon emission computed tomography/
omputed tomography (SPECT/CT) images for the identification of sentinel nodes
n the hilum for patients with clinical stage Ia non–small cell lung cancer.
ethods: Technetium-99m tin colloid was injected into the peritumoral region
pproximately 18 hours before surgery in 63 patients with clinical stage Ia non–
mall cell lung cancer. On the morning of the operation, approximately 16 hours
fter administration of tin colloid, sentinel nodes were identified by fused SPECT/
T; this was followed by intraoperative sentinel node identification in the dissected
ymph nodes by gamma probe. Because the gamma probe is a standard method for
entinel node identification, the sensitivity of fused SPECT/CT images was exam-
ned on the basis of the data of the gamma probe.
esults: Fused SPECT/CT images could identify sentinel nodes at segmental and
obar lymph nodes with a sensitivity of 0.87 and 0.74, both of which were
ignificantly higher than 0.40 in the mediastinum (P  .001 and P  .012,
espectively). In 5 patients with pathologic N1 or N2 disease, both SPECT/CT and
he gamma probe could identify sentinel nodes with metastases.
onclusions: SPECT/CT could identify sentinel nodes of the hilum especially in
egmental and lobar lymph nodes but not in the mediastinum. Because the gamma
robe can identify sentinel nodes before nodal dissection in the mediastinum but not
n the hilum, a combination of SPECT/CT and the gamma probe can be used to
dentify sentinel nodes before nodal dissection in both the hilum and the mediasti-
um, which will enable sentinel node navigation surgery in non–small cell lung
ancer.
entinel lymph node (SN) sampling with a gamma probe has allowed surgeons
to be more selective in performing a formal lymph node dissection in
melanoma, breast cancer, and gastrointestinal cancers.1-3 However, the
amma probe method in lung cancer surgery cannot identify SNs before lymph node
issection in the hilum owing to high radioactivity from primary tumors.4,5 There-
ore, previously reported SN identifications with the gamma probe method in lung
ancer surgery have been based on radioactivity measured in the dissected lymph
odes,5-10 which cannot be used to guide lymph node dissection or sampling
ifficulty with the gamma probe method makes it difficult for SN navigation surgery
o be of practical use in non–small cell lung cancer (NSCLC).
Planar scintigram with a radioactive colloid has also been used to identify SNs,
specially in melanoma of the head and neck.11-13 However, in lung cancer surger
ocalization of nodal stations by planar scintigram is difficult because SNs cannot
vascular Surgery ● July 2007
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TSeadily be discriminated owing to the lack of tomography
mages. In 2002, we installed a combined single photon
mission computed tomography/computed tomography (SPECT/
T) system that is composed of a gantry-free gamma cam-
ra and an 8-row multidetector CT. So that we can avoid
ositional differences between the SPECT and CT studies,
maging is performed on the same platform, which makes
usion of SPECT and high-performance CT images possi-
le. Because the SPECT/CT system has enabled us to iden-
ify SNs on the basis of the fusion images, without the
dverse effect of overlapping radioactivity from the primary
ite, it allows preoperative SN localization in relation to
earby anatomic structures, which enables an intraoperative
N biopsy to be easy and accurate. We14 previously iden-
ified SNs in 35 patients with melanoma by the SPECT/CT
ystem; the identification rate was 100%.14 The present
tudy evaluated the usefulness of fused SPECT/CT images,
ompared with the gamma probe, for SN identification in
ung cancer surgery.
atients and Methods
atient Eligibility
his study of SN identification in patients with clinical stage Ia
SCLC was approved by the ethical committee of the Graduate
chool of Medical Sciences, Kumamoto University, in March
005. Clinical staging was performed by body CT, brain magnetic
esonance imaging, and positron emission tomography. Informed
onsent was obtained from all patients after a discussion with the
urgeons regarding the risks and benefits. Eligible patients had
linical stage Ia peripheral type NSCLC and were candidates for
obectomy or segmentectomy with mediastinal lymph node dis-
ection. The patients without preoperative histologic diagnosis of
umors were excluded. The lobectomy with mediastinal lymph
ode dissection was performed via thoracoscopy, as described
efore.15 Segmentectomy with hilar and mediastinal lymph n
issection was performed via open thoracotomy, as described
efore.16 All of the lymph nodes at the hilum were diss
uring segmentectomy with taping of the vessels and bronchus.
ymph Node Nomenclature
he lymph node nomenclature used was based on the original
ymph node map for lung cancer.17
dministration of Radioactive Colloid
dministration of the radioactive colloid was based on the method
Abbreviations and Acronyms
CT  computed tomography
NSCLC non–small cell lung cancer
SN  sentinel lymph node
SPECT  single photon emission computed tomography
99mTc  technetium-99meported previously.4,5 In the SPECT/CT room, approximately 18 t
The Journal of Thoracicours before the operation, 6 to 8 mCi of technetium-99m (99mTc)
in colloid suspended in a volume of 1 to 1.5 mL was injected into
he peritumoral region.
PECT/CT System
n the morning of the operation, approximately 16 hours after
dministration of the 99mTc tin colloid, SNs were identified by the
PECT/CT system. This system was composed of a commercially
vailable gantry-free SPECT with dual-head detectors (Skylight;
DAC Laboratories, Milpitas, Calif) and an 8 multidetector-row
T scanner (Light-Speed Ultra Instrument; General Electric, Mil-
aukee, Wis). The two instruments were juxtaposed so that the CT
able bearing the patient could be moved directly into the SPECT
canner before CT scanning. As a result, each patient was identi-
ally positioned for SPECT and CT imaging.
SPECT data acquisition was performed with a vertex general-
urpose parallel-hole (VXGP) collimator. A 360 SPECT scan was
cquired and was followed by CT scanning. Reconstructive CT
mages were processed into Digital Imaging and Communications
n Medicine (DICOM) data and then transferred to Pegasys
ADAC Laboratories, Milpitas, Calif), which is a workstation for
PECT processing. One lumen of a 3-way stopcock (inner diam-
ter 4 mm, length 10 mm) containing an aqueous solution of 99mTc
in colloid and a contrast medium was used as an external fiducial
arker. So that a precise record of both images could be obtained,
xternal fiducial markers were fixed to the common platform for
PECT and CT imaging. The two scans were performed sequen-
ially. Fusion of the SPECT images with the CT images was
anually performed by aligning the external fiducial markers of
he two images on the workstation, enabling localization of SN on
T images (Figure 1). An SN was visually identified on
PECT/CT images by two experienced radiologists before surgery
S.S. and K.K).
amma Probe Method
he radioactivity of the dissected lymph nodes was determined by
handheld gamma probe (Navigator; Auto Suture Japan, Tokyo,
apan), as reported previously.4,5 An SN was defined as any n
or which the radioactivity count was 10 times that of the back-
round level.
athologic Examination
Ns were examined by intraoperative frozen section analysis using
- to 3-mm thick sections. The dissected lymph nodes were ex-
mined histologically by use of formalin-fixed and paraffin-
mbedded sections with hematoxylin and eosin staining.
tatistical Analysis
ecause the use of a gamma probe to measure radioactivity of
issected lymph nodes is now a standard method for SN identifi-
ation, the sensitivity of SPECT/CT was examined on the basis of
ata gathered with the gamma probe, which was calculated as true
ositive/true positive  false negative. All data were analyzed for
tatistical significance by the 2 test. All values in the text and
ables are given as mean  standard deviation.
and Cardiovascular Surgery ● Volume 134, Number 1 183
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1
G
TSesults
rom April 2005 to September 2006, 79 patients with clin-
cal stage Ia peripheral NSCLC underwent surgery at the
epartment of Thoracic Surgery of Kumamoto University
ospital. Of these, 16 patients could not be enrolled in this
tudy because of the following reasons: (1) Preoperative
istologic diagnosis was not obtained in 5 patients; (2)
PECT/CT could not be used because of the other exami-
ations in 10 patients; and (3) one patient refused to partic-
pate in the study. As a result, 63 consecutive patients were
nrolled in this study. The gamma probe identified SNs in
9 (78%) of the 63 patients, whose pathologic N stages were
0 in 44, N1 in 2, and N2 in 3 (Table 1). SPECT/CT
dentify SNs in 39 (62%) patients, whose pathologic N
tages were N0 in 34, N1 in 2, and N2 in 3 (Table 
N identification rate by SPECT/CT imaging was lower
han that achieved by the gamma probe with marginal
ignificance (P .052). The mean number of SNs identified
y the gamma probe in the 48 patients was 1.6 0.8 (range:
-4); the value obtained by SPECT/CT in the 38 patients
as 1.5  0.6 (range: 1-3). However, there was no signif-
igure 1. Fused SPECT/CT images in lung cancer of the left upper
obe. A, Primary tumor. B, Radiolabeled lymph node (segmental
odal station) can be detected (arrow).cant difference between the two methods in this respect. t
84 The Journal of Thoracic and Cardiovascular Surgery ● Julyuld
The
etween the 49 patients with identifiable SNs and the 14
ithout by gamma probe, the mean age was younger and the
ean tumor size was smaller in the former than in the latter,
ith significance (P  .01 and .024, respectively). How-
ver, there were no significant differences of other variables
etween patients with identifiable SNs and those without
hen both the gamma probe and SPECT/CT were used.
umors in 2 patients were pathologically classified as T2:
ne tumor was involved over the pleura and the other one
as larger than 3 cm in the permanent section. Although 2
atients needed tube drainage because of pneumothorax
fter the injection of the isotope, there were no other
omplications.
Table 3 shows the correlation between SPECT/CT 
ging and the gamma probe method for SN identification at
ach nodal station of the hilum and mediastinum in the 49
atients whose SNs were identified by gamma probe. In the
ymph node stations at the hilum, the gamma probe and
PECT/CT corresponded with each other in 46 (94%) pa-
ABLE 1. Patient characteristics of SN identification by
amma probe
Sentinel nodes by gamma
probe
Identified Not identified
ge (y)
Mean  SD 68  7 74 8*
Range 53-81 65-82
ex (No.)
Male 25 10
Female 24 4
ean tumor size (mm) 19 7 24 8†
umor location (No.)
Right upper lobe 13 3
Right middle lobe 2 1
Right lower lobe 8 3
Left upper lobe 17 5
Left lower lobe 9 2
istologic type (No.)
Adenocarcinoma 44 8
Squamous cell carcinoma 3 6
Adenosquamous carcinoma 1 0
Small cell carcinoma 1 0
perative procedure (No.)
Lobectomy 7 4
Segmentectomy 42 10
-TNM (No.)
T1 N0 M0 43 13
T2 N0 M0 1 1
T1 N1 M0 2 0
T1 N2 M0 3 0
otal 49 14
N, Sentinel node. *P  .01; †P  .024.ients at nodal station No. 10, 46 (94%) at No. 11, 42 (86%)
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G
TSt No. 12, and 39 (80%) at No. 13. In the mediastinum of the
ight lung, the gamma probe and SPECT/CT corresponded
ith each other in 21 (91%) patients at nodal station No. 3,
n 22 (96%) at No. 4, and in 22 (91%) at No. 7. In the
ediastinum of the left lung, the gamma probe and
PECT/CT corresponded with each other in 26 (100%)
atients at nodal station No. 4, in 22 (85%) at No. 5, and in
2 (85%) at No. 7. SNs were not identified at the other
ediastinal nodal stations, that is, Nos. 1, 2, 8, and 9, using
oth methods.
The sensitivity of SPECT/CT based on Table 3 was 
t nodal station No. 13, 0.74 at No. 12, 0.63 at No. 11, 0.40
t No. 10, and 0.31 at the mediastinal nodal stations (Figu
he sensitivity of SPECT/CT decreased numerically from
odal station No. 13 to No. 10 and was the lowest in the
ediastinal lymph nodes. The sensitivity of SPECT/CT in
he mediastinal lymph nodes was significantly lower than
hose at nodal station No. 13 and No. 12 (P  .001 and
 .012, respectively). The specificity of SPECT/CT based
n Table 3 was 0.76 at No. 13, 0.93 at N0. 12, 1.0 at
.0 at No. 10, and 0.99 at the mediastinum.
ABLE 2. Patient characteristics of SN identification by
PECT/CT
SNs by SPECT/CT
Identified Not identified
ge (y)
Mean  SD 68  6 69 7
Range 54-81 53-82
ex (No.)
Male 20 15
Female 19 9
ean tumor size (mm) 19 7 20 7
umor location (No.)
Right upper lobe 11 5
Right middle lobe 0 3
Right lower lobe 7 4
Left upper lobe 15 7
Left lower lobe 6 5
istologic type (No.)
Adenocarcinoma 34 18
Squamous cell carcinoma 4 5
Adenosquamous carcinoma 0 1
Small cell carcinoma 1 0
perative procedure (No.)
Lobectomy 5 6
Segmentectomy 34 18
TNM (No.)
T1 N0 M0 33 23
T2 N0 M0 1 1
T1 N1 M0 2 0
T1 N2 M0 3 0
otal 39 24N, Sentinel node; SPECT/CT, single photon emission computed tomography.
The Journal of Thoracic).
 11,
Pathologic examination showed lymph node metastases
n 5 patients, that is, N1 in 2 patients and N2 in 3 (T
rozen section of the SNs identified by both SPECT/CT and
he gamma probe could show metastases in all 5 patients.
iscussion
he present study demonstrated that SPECT/CT was infe-
ior to the gamma probe method for SN identification in the
ediastinal lymph nodes. This discrepancy could be caused
y the following: (1) the ability to measure radioactivity
ith SPECT/CT images is inferior to that of direct mea-
ABLE 3. Correlation between SPECT/CT and gamma
robe for SN identification
Patient number with SN identified by
Gamma probe () Gamma probe ()
SPECT
()
SPECT
()
SPECT
()
SPECT
()
tation
True
positive
False
negative
False
positive
True
negative Total
ilum
10 2 3 0 44 49
11 5 3 0 41 49
12 14 5 2 28 49
13 23 5 5 16 49
ediastinum
Right
3 1 2 0 20 23
4 1 1 0 21 23
7 0 1 0 22 23
Left
4 1 0 0 25 26
5 2 3 1 20 26
7 0 4 0 22 26
N, Sentinel node; SPECT/CT, single photon emission computed tomogra-
hy. , Sentinel node is identified; , sentinel node is not identified.Figure 2. Sensitivity of SPECT/CT at each lymph node station.
and Cardiovascular Surgery ● Volume 134, Number 1 185
sm
b
T
t
i
s
b
t
e
w
i
 a
g
a
t
(
t
p
i
b
u
m
b
N ec
t
b
n
N CT
c
m
S
g
f
c
S
h
m
i
S
t
i
c
d
b
1
N
i
t
a
u
S
s
p
t
u
t
o
u
i
m
a
i
m
w
i es.
W
c
i
S
4
fl
t
j
i
i
u
T
N
S
a
General Thoracic Surgery Nomori et al
1
G
TSurement by a gamma probe and (2) the radioactivity of
ediastinal SNs is usually lower than that of hilar SNs,
ecause the former is further away from the primary tumor.
herefore, we conclude that SPECT/CT cannot easily iden-
ify SNs in the mediastinum. However, SPECT/CT could
dentify SNs at nodal station No. 12 and No. 13 with a
ensitivity of 0.82 and 0.74, respectively. This may be
ecause SNs at nodal station No. 12 and No. 13 are close to
he primary tumor, which makes their radioactivity high
nough for detection by SPECT/CT. In fact, in 5 patients
ith N1 or N2 disease, SPECT/CT imaged metastatic SNs
n the hilum before the operation.
We4 previously evaluated SN identification by using
amma probe in 104 patients with clinical stage I NSCLC
nd concluded that although the gamma probe could iden-
ify SNs in the mediastinum before lymph node dissection
in vivo SN identification), it could not in the hilum owing
o high radioactivity from primary tumors. Because the
resent study showed the usefulness of SPECT/CT for the
n vivo SN identification in the hilum, we believe that the com-
ination of SPECT/CT and the gamma probe could be
seful for in vivo SN identification in both the hilum and the
ediastinum.
Recently, it has been reported that segmentectomy could
e an alternative to lobectomy for pathologic T1 N0 M0
SCLC.16,18,19 So that the final indication of segment-
omy can be determined, intraoperative frozen sections must
e examined for all of the hilar and lobe-specific mediasti-
al lymph nodes to confirm the intraoperative N stage to be
0.18,19 We consider that the application of SPECT/
ould be used for determining the final indication of seg-
entectomy as follows: (1) SNs identified in the hilum by
PECT/CT and those identified in the mediastinum by
amma probe are submitted for frozen sections; (2) when
rozen sections of SNs show metastases, segmentectomy is
onverted to lobectomy. Even after segmentectomy, in vivo
N identification by gamma probe is usually difficult for the
ilum owing to high radioactivity in the remaining seg-
ents. Therefore, if SPECT/CT is not used, all lymph nodes
n the hilum have to be dissected during segmentectomy for
ABLE 4. SNs identified by SPECT/CT and gamma probe in
o. Age/sex Tumor location Histology M
1 60/M RLL Ad N
2 72/M RLL Ad N
3 80/M LUL Ad N
4 59/M LUL Ad N
5 54/F LLL Ad N
PECT/CT, Single photon emission computed tomography/computed tom
denocarcinoma.N identification by gamma probe, which is hard as well as l
86 The Journal of Thoracic and Cardiovascular Surgery ● Julyime-consuming. On the other hand, for lobectomy, SN
dentification by SPECT/CT would not be necessary be-
ause lymph nodes at the hilum are routinely removed
uring lobectomy and can be examined for SN identification
y gamma probe.
The sensitivities of SN identification at nodal station No.
0 and No. 11 by SPECT/CT were still low. Because station
o. 10 is close to the mediastinum, the gamma probe can
dentify SNs at this station after resection of the primary
umor, as there will no longer be any interference of radio-
ctivity from the primary tumor. Nodal station No. 11 is
sually easy to excise even during segmentectomy, enabling
N identification by gamma probe.
Several tracers have been used for SN identification,
uch as 99mTc tin colloid, 99mTc sulfur colloid, and 99mTc
hytate. Of these, 99mTc tin colloid has the largest particles,
hat is, about 1000 nm in diameter. The reason that we have
sed 99mTc tin colloid is as follows. Because the particles of
in colloid are large, they take longer to reach SNs than the
ther tracers with small particles. In lung cancer surgery,
nlike operations for cancer in other organs, radioisotope
njected frequently leaks into the tracheobronchus, which
akes in vivo SN identification unreliable immediately
fter the injection. Because 99mTc tin colloid has to be
njected a few hours before the operation to reach SNs, the
aterial that leaked into the tracheobronchus is already
ashed out at surgery, resulting in more reliable in vivo SN
dentification than the other tracers with small particl4
e4 previously confirmed that the radioactivity of 99mTc tin
olloid in SNs was stable from 9 to 24 hours after the
njection. On the other hand, 99mTc sulfur colloid can reach
Ns rapidly because of their small particles, approximately
0 nm in diameter, but could pass through the true SNs and
ow further up the chain of nodes, resulting in false nega-
ive results. Therefore, 99mTc sulfur colloid has to be in-
ected immediately before surgery, which would make the
n vivo SN identification difficult because of material leak-
ng into the tracheobronchus. In fact, the previous reports
sing 99mTc sulfur colloid identified SNs in the dissected
ients with N1 or N2 disease
SN
tic node SPECT/CT Gamma probe pTNM
No. 13 No. 13 T1 N1 M0
No. 11 No. 11 T1 N1 M0
No. 5 No. 5 T1 N2 M0
, 12, 13 Nos. 12, 13 Nos. 5, 12 T1 N2 M0
, 11, 12 Nos. 12, 13 No. 12 T1 N2 M0
hy; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe; Ad,pat
etasta
o. 13
o. 11
o. 5
os. 5
os. 7
ograpymph nodes but not with in vivo identification.6,7
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Nomori et al General Thoracic SurgeryIn conclusion, SPECT/CT can be used to identify SNs in
he hilum before surgery, especially at nodal station No. 12
nd No. 13, but not in the mediastinum. Because the gamma
robe method can identify SN before lymph node dissection
n the mediastinum but not in the hilum, a combination of
PECT/CT and the gamma probe could be used to identify
Ns before lymph node dissection in both the hilum and the
ediastinum. This will enable SN navigation surgery in
atients with clinical stage Ia NSCLC, especially for
egmentectomy.
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